Table 2.
Treatment characteristics
|
|
Covered self-expandable metal stents
|
Multiple plastic stents
|
P value
|
| Stent treatment duration (days) | |||
| Median | 381 | 390 | 0.531 |
| Total number of ERCP | |||
| Median | 2 | 5 | 0.001 |
| Number of stents per ERCP/patient | |||
| Median | 1 | 4 | 0.001 |
| Range | 1-3 | 1-6 | |
| Total number of stents per patients | |||
| Median | 1 | 12 | 0.001 |
| Range | 1-3 | 1-27 | |
| Adverse events | |||
| Sphincterotomy bleeding | 3 | 1 | |
| Dilatation bleeding | 1 | 0 | |
| Choledocholithiasis/occlusion of stent | 25 | 7 | |
| Acute pancreatitis | 7 | 0 | |
| Cholangitis | 4 | 0 | |
| Perforation | 1 | 1 | |
| Stricture after sphincterotomy | 0 | 1 | |
| Hemobilia | 0 | 0 | |
| Abdominal pain | 0 | 0 | |
| Stricture caused by the stent | 3 | 0 | |
| Technical difficulty in removing the stent | 0 | 0 | |
| Bleeding removing the stent | 1 | 0 | |
| Death | 12 | 4 | 0.504 |
| Death related to ERCP procedure | 0 | 0 |
ERCP: Endoscopic retrograde cholangiopancreatography.